本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

534.49
+1.370.26%
盤後534.490.00000.00%19:30 EDT
成交量:18.76萬
成交額:1.01億
市值:123.23億
市盈率:-37.60
高:546.56
開:536.02
低:531.37
收:533.12
52周最高:615.00
52周最低:393.61
股本:2,305.55萬
流通股本:1,372.50萬
量比:0.91
換手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
淨資產收益率:-53.31%
總資產收益率:-17.84%
市淨率:23.53
市盈率(LYR):-41.59

資料載入中...

2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

重要事件披露

Form 8-K - Current report
2026/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/17

重要事件披露

Form 8-K - Current report
2026/06/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

重要事件披露

Form 8-K - Current report
2026/04/28

重要事件披露

Form 8-K - Current report
2026/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities